Notably, ASS1 deficiency has been associated with clinically aggressive states of nasopharyngeal carcinoma and pancreatic ductal adenocarcinoma (Lan et al., 2014; Liu et al., 2017). Here, ASS1 is linked to pancreatic ductal adenocarcinoma.